KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Global Medical REIT (GMRE) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Global Medical REIT (GMRE) over the last 12 years, with Q2 2025 value amounting to $38.5 million.

  • Global Medical REIT's Capital Expenditures rose 773690.48% to $38.5 million in Q2 2025 from the same period last year, while for Sep 2025 it was $120.9 million, marking a year-over-year increase of 26852.97%. This contributed to the annual value of $81.7 million for FY2024, which is 356251.12% up from last year.
  • Global Medical REIT's Capital Expenditures amounted to $38.5 million in Q2 2025, which was up 773690.48% from $32.0 million recorded in Q1 2025.
  • Global Medical REIT's Capital Expenditures' 5-year high stood at $75.4 million during Q2 2022, with a 5-year trough of -$2.2 million in Q3 2023.
  • In the last 5 years, Global Medical REIT's Capital Expenditures had a median value of $28.2 million in 2021 and averaged $27.6 million.
  • Per our database at Business Quant, Global Medical REIT's Capital Expenditures crashed by 12361.76% in 2024 and then surged by 773690.48% in 2025.
  • Over the past 5 years, Global Medical REIT's Capital Expenditures (Quarter) stood at $26.5 million in 2021, then crashed by 98.74% to $335000.0 in 2022, then soared by 352.84% to $1.5 million in 2023, then soared by 3222.02% to $50.4 million in 2024, then dropped by 23.62% to $38.5 million in 2025.
  • Its last three reported values are $38.5 million in Q2 2025, $32.0 million for Q1 2025, and $50.4 million during Q4 2024.